Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Eddy Pasquier, Joseph Ciccolini, Manon Carre, Sarah Giacometti, Raphaelle Fanciullino, Charlotte Pouchy, Marie-Pierre Montero, Cindy Serdjebi, Maria Kavallaris, Nicolas Andre
Published Oct 17, 2011 · Vol. 2, No. 10 · pp. 797-809
Michael Christoph Haffner, Alcides Chaux, Alan K Meeker, David Esopi, Jonathan Gerber, Laxmi G. Pellakuru, Antoun Toubaji, Pedram Argani, Christine Iacobuzio-Donahue, William G. Nelson, George J. Netto, Angelo DeMarzo, Srinivasan Yegnasubramanian
Published Sep 2, 2011 · Vol. 2, No. 8 · pp. 627-637
Melissa L. Sokolosky, Kristin M. Stadelman, William H. Chappell, Stephen L. Abrams, Alberto M. Martelli, Franca Stivala, Massimo Libra, Ferdinando Nicoletti, Lyudmyla B. Drobot, Richard A. Franklin, Linda S. Steelman, James A. McCubrey
Published Jul 1, 2011 · Vol. 2, No. 7 · pp. 538-550
Keywords: Akt, mTOR, Targeted Therapy, Drug Resistance
Asfar S. Azmi, Sanjeev Banerjee, Shadan Ali, Zhiwei Wang, Bin Bao, Frances WJ Beck, Anthony F. Shields, Philip Philip, Fazlul H. Sarkar, Ramzi M. Mohammad
Published May 16, 2011 · Vol. 2, No. 5 · pp. 378-392